A Bio‐Liposome Activating Natural Killer Cell by Illuminating Tumor Homogenization Antigen Properties

Natural killer (NK) cell therapies, primarily based on chimeric antigen receptor NK cells (CAR‐NK), have been developed and applied clinically for therapeutic treatment of patients with mid‐to‐late‐stage tumors. However, NK cell therapy has limited efficacy due to insufficient antigen expression on...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xue, Bian, Jiayi, Wang, Zheng, He, Mengning, Yang, Ying, Li, Quanhao, Luo, Xinping, Zhou, Zhanwei, Li, Jing, Ju, Shenghong, Sun, Minjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131854/
https://www.ncbi.nlm.nih.gov/pubmed/36852735
http://dx.doi.org/10.1002/advs.202205449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131854/
https://www.ncbi.nlm.nih.gov/pubmed/36852735
http://dx.doi.org/10.1002/advs.202205449

Ejemplares similares